FGFR4 and hepatocellular carcinoma: The results revealed that the SNP combination pattern of the NOS3 rs2070744 and FGFR4 rs351855 genotypes was helpful as treatment effect predictors and prognostic factors for HCC patients treated with lenvatinib.